Clinical Trial: A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07700212) titled 'A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma' on July 08.

Brief Summary: The goal of this clinical research study is to learn about the safety and tolerability of the OnVagus device when used by patients who have metastatic pancreatic cancer and are receiving chemotherapy.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Metastatic Pancreatic Adenocarcinoma

Intervention: DEVICE: Transcutaneous LFVB (tLFVB)

The transcutaneous LFVB (tLFVB), involves placing a superficial, transcutaneous device over the rig...